Healthcare -
Drug Manufacturers - General - NYSE - CH
$ 97.53
-0.337 %
$ 191 B
Market Cap
17.02
P/E
NVS - STOCK-BASED COMPENSATION
Stock-based Compensation NVS - Novartis AG
865 M
LAST VALUE
11.16%
2 YEAR CAGR
2.65%
5 YEAR CAGR
1.71%
10 YEAR CAGR